Leuprolide acetate for exhibitionism in huntington's disease

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1994 English Publisher:WileyJournal:Movement Disorders, volume 9, pages 353-357 (issn: 0885-3185, eissn: 1531-8257,

Copyright policy )

Authors: S S, Rich; F, Ovsiew;

doi: 10.1002/mds.870090317

pmid: 8041380

Leuprolide acetate for exhibitionism in huntington's disease

- Summary
- Subjects
- Metrics

Abstract

AbstractWe treated a patient with Huntington's disease and exhibitionism using leuprolide acetate (Lupron Depot, TAP Pharmaceuticals), a gonadotropin‐releasing hormone agonist. The result was elimination of his deviant sexual behavior with few side effects. This regimen may be a safe and effective pharmacological treatment of the paraphilias. The occurrence of paraphilias in basal ganglia disorders is reviewed.

Related Organizations

University of Illinois at Chicago
United States
University of Chicago
United States

Keywords

Adult, Male, Neurologic Examination, Exhibitionism, Huntington Disease, Delayed-Action Preparations, Humans, Dementia, Leuprolide, Injections, Intramuscular

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	37
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average